All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

267

Reset

267 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • IanalumabVAY736, VAY736 AIPhase 318 trials

    Novartis · Primary Immune Thrombocytopenia (ITP), Systemic Lupus Erythematosus, Sjogren Syndrome

  • AK117Phase 314 trials

    Akeso · Advanced Malignant Tumors, ACUTE MYELOID LEUKEMIA; AML, Higher-risk Myelodysplastic Syndromes

  • BrenipatideLY3537031Phase 313 trials

    Eli Lilly · Alcohol Use Disorder, Irritable Bowel Syndrome, Depressive Disorder, Major

  • PovorcitinibINCB054707, INCB54707Phase 312 trials

    Incyte · Hidradenitis Suppurativa (HS), NonSegmental Vitiligo, Prurigo Nodularis

  • APG-2575lisaftoclaxPhase 310 trials

    Ascentage Pharma Group Inc. · CLL/SLL, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

  • AZD0120GC012FPhase 39 trials

    AstraZeneca · Newly Diagnosed Multiple Myeloma (NDMM), Relapsed AL Amyloidosis, Refractory AL Amyloidosis

  • EtentamigABBV-383, TNB-383BPhase 38 trials

    AbbVie · Multiple Myeloma, Relapsed or Refractory Multiple Myeloma, Amyloid Light Chain (AL) Amyloidosis

  • CM336group, QiShen YiQi Dripping Pills 3 bagsPhase 37 trials

    Keymed Biosciences Co.Ltd · Multiple Myeloma (MM), Primary Light-Chain Amyloidosis, Primary Immune Thrombocytopenia

  • GlucocorticoidsPhase 37 trials

    Novartis · VEXAS Syndrome, ANCA Associated Vasculitis (AAV), Anti-Glomerular Basement Membrane Disease

  • IMVT-1402Phase 37 trials

    Immunovant Sciences GmbH · Graves' Disease, Rheumatoid Arthritis, Subacute Cutaneous Lupus Erythematosus

  • ObicetrapibPhase 37 trials

    NewAmsterdam Pharma · Lipidemia, Preclinical Alzheimer's Disease, Antioxidant Absorption

  • siRNAADX-038, ADX-324Phase 37 trials

    ADARx Pharmaceuticals, Inc. · Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1

  • AND017Phase 36 trials

    Kind Pharmaceuticals LLC · Anemia Due to Chronic Kidney Disease, β -Thalassemia, Cancer-Related Anemia

  • ElriterceptTAK-226, KER-050Phase 36 trials

    Takeda · Myelodysplastic Syndromes, Myelofibrosis, Anemia

  • LUM-201Phase 36 trials

    Lumos Pharma · Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), Obesity & Overweight

  • NizubaglustatAZ-3102Phase 36 trials

    Azafaros B.V. · Niemann-Pick Type C Disease, GM2 Gangliosidosis, GM1 Gangliosidosis

  • CRN04894AtumelnantPhase 35 trials

    Crinetics Pharmaceuticals Inc. · Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia, Cushing Syndrome

  • DeucrictibantPHVS416, PHA121Phase 35 trials

    Pharvaris Netherlands B.V. · Hereditary Angioedema (HAE), Hereditary Angioedema, Hereditary Angioedema Type I

  • MibavademabREGN4461Phase 35 trials

    Regeneron · Generalized Lipodystrophy, Functional Hypothalamic Amenorrhea, FHA

  • NPI-001N-Acetylcysteine AmidePhase 35 trials

    Nacuity Pharmaceuticals, Inc. · Retinitis Pigmentosa (RP), Usher Syndrome, Alzheimer´s Disease

  • VenglustatGZ402671Phase 35 trials

    Sanofi · Fabry Disease, Gaucher's Disease Type III, Gaucher Disease Type 1

  • AlimatravirMK-8527Phase 34 trials

    Merck & Co. · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis, HIV

  • BPN14770zatolmilastPhase 34 trials

    Tetra Discovery Partners · Fragile X Syndrome, Jordan's Syndrome, PPP2R5D Neurodevelopmental Disorder

  • CamlipixantBLU-5937Phase 34 trials

    GSK · Refractory Chronic Cough, Cough, Irritable Bowel Syndrome

  • GlepaglutideZP1848Phase 34 trials

    Zealand Pharma · Short Bowel Syndrome, Short Bowel Syndrome (SBS)

  • InpegsomatropinPhase 34 trials

    Xiamen Amoytop Biotech Co., Ltd. · Turner Syndrome, Idiopathic Short Stature, Adult Growth Hormone Deficiency

  • JNT-517Phase 34 trials

    Otsuka · Phenylketonuria (PKU), Phenylketonuria

  • Kedrion IVIG 10%KIg 10, Immune globulin 10% for administrationPhase 34 trials

    Kedrion S.p.A. · Primary Immunodeficiency Disease, Chronic Primary Immune Thrombocytopenia (ITP), Chronic Inflammatory Demyelinating Polyneuropathy

  • LP352bexicaserinPhase 34 trials

    Longboard Pharmaceuticals · Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome

  • NTI164FEN164Phase 34 trials

    Fenix Innovation Group · Rett Syndrome, Autism, Autism Spectrum Disorder

  • SCTC21CPhase 34 trials

    Sinocelltech Ltd. · IgA Nephropathy, Multiple Myeloma (MM), Systemic Lupus Erythematosus (SLE)

  • SR604Phase 34 trials

    Shanghai RAAS Blood Products Co., Ltd. · Factor VII Deficiency, Hemophilia A, Hemophilia B

  • ACC017Phase 33 trials

    Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Infection, Human Immunodeficiency Virus

  • ALK-001C20-D3-Retinyl Acetate, C20 Deuterated vitamin APhase 33 trials

    Alkeus Pharmaceuticals, Inc. · Stargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy

  • AOC 1044Phase 33 trials

    Avidity Biosciences, Inc. · DMD, Duchenne Muscular Dystrophy, Exon 44

  • BBP-418ribitolPhase 33 trials

    ML Bio Solutions, Inc. · Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I), LGMD2I

  • DazodalibepVIB 4920, MEDI 4920Phase 33 trials

    Amgen · Sjögren's Syndrome (SS), Sjögren's Syndrome, Sjogren's Syndrome

  • Del-desiranAOC 1001Phase 33 trials

    Avidity Biosciences, Inc. · DM1, Myotonic Dystrophy, Myotonic Dystrophy 1

  • delpacibart braxlosiranAOC-1020, del-braxPhase 33 trials

    Avidity Biosciences, Inc. · FSHD, FSHD1, FSHD2

  • FazirsiranTAK-999, ARO-AATPhase 33 trials

    Takeda · Alpha1-Antitrypsin Deficiency

  • ICP-488Phase 33 trials

    Beijing InnoCare Pharma Tech Co., Ltd. · Plaque Psoriasis Patients, Primary Sjögren's Syndrome, Cutaneous Lupus Erythematosus (CLE)

  • KVD900Phase 33 trials

    KalVista Pharmaceuticals, Ltd. · Hereditary Angioedema

  • MilvexianJNJ-70033093, BMS-986177Phase 33 trials

    Johnson & Johnson (Janssen) · Ischemic Stroke; Ischemic Attack, Transient, Atrial Fibrillation, Acute Coronary Syndrome

  • obudanersenION582Phase 33 trials

    Ionis Pharmaceuticals · Angelman Syndrome

  • QRX003Phase 33 trials

    Quoin Pharmaceuticals · Netherton Syndrome

  • RO7204239Phase 33 trials

    Roche (Genentech) · Obesity, Overweight, Overweight With One Weight Related Comorbidity

  • ULOMK-8507, UlonivirinePhase 33 trials

    Merck & Co. · Human Immunodeficiency Virus Type 1 (HIV-1) Infection, HIV-1 Infection

  • 2 NRTIsPhase 32 trials

    Merck & Co. · Human Immunodeficiency Virus (HIV) Infection, Infection, Human Immunodeficiency Virus, HIV Infections

  • AAV2-hRPE65v2voretigene neparvovec-rzylPhase 32 trials

    Roche (Genentech) · Leber Congenital Amaurosis, Inherited Retinal Dystrophy Due to RPE65 Mutations

  • AcotiamideItopride HydrochloridePhase 32 trials

    Getz Pharma · Postprandial Distress Syndrome, Functional Dyspepsia

Page 1 of 6Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.